Nevro Corp. ( NVRO) - Key Metrics
Stock symbol NVRO is outdated, potentially delisted? Maybe it is available on other exchange?
NVRO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $2.81 | -$1.41 | $0.49 | $0.44 |
| 2024Q3 | $2.60 | -$0.41 | $0.07 | $0 |
| 2024Q2 | $2.82 | -$0.53 | -$0.22 | -$0.29 |
| 2024Q1 | $2.79 | -$0.70 | -$0.90 | -$0.98 |
| 2023Q4 | $3.20 | -$0.25 | -$0.41 | -$0.46 |
NVRO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | -0.66 |
| 2024Q3 | ? | -3.40 |
| 2024Q2 | ? | -4.06 |
| 2024Q1 | ? | -4.78 |
| 2023Q4 | ? | -21.73 |
NVRO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q4 | 11.86% | ? |
| 2024Q3 | 0.08% | ? |
| 2024Q2 | -3.31% | ? |
| 2024Q1 | -7.35% | ? |
| 2023Q4 | -2.13% | ? |
NVRO
Price: $5.84
52 week price:
Earnings Per Share: -3.06 USD
P/E Ratio: -1.91
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 496000
Ebitda: -2.7 millionMarket Capitalization: 224.1 million